Want a bespoke baby? Check the beauty, brains, or brawn boxes on the embryo order form. Genetic tinkering is no longer science fiction—it’s a market without legal guidelines or societal buy-in. But ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...

SRT CEO Patrick Girondi and Artist and Project Manager Megan Euker with newly restored San Rocco sculpture, Altamura, Italy.

The Centers for Medicare and Medicaid Services has named 33 states, as well as Washington, D.C., and Puerto Rico, as participants in its Cell and Gene Therapy Access Model, which is designed to treat ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

The participating regions are home to 84 percent of sickle cell Medicaid patients who could gain access to gene therapies under outcomes-based agreements.

CMS has reached agreements with drug manufacturers to provide gene therapies to treat sickle cell disease to Medicaid recipients under a new outcomes-based model. A total of 33 states, including the ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and more.

The US regulator has launched a new national initiative to help Medicaid programs fund gene therapies for sickle cell disease ...

The Executive Director of the Ghana Foundation for Sickle Gene Action, Victoria Awo Twumasi, has appealed to President John Dramani Mahama to include full coverage of sickle cell disease (SCD) treatme ...